Report on large shareholdings (general)
6.1
주식회사 엘앤씨바이오
1100
0100
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-11-12 |
| To: Korea Exchange | Report reference date: | 2026-11-17 |
| Reporting person: | 이 환 철 |
| Summary |
| Issuer name | 주식회사 엘앤씨바이오 | Relationship to Issuer | Largest Shareholder |
| Report Type | 변동ㆍ변경 |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | 12,584,444 | 20.59 |
| Current Report | 12,708,504 | 20.80 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | 1,900,000 | 3.11 |
| Current Report | 3,800,000 | 6.22 |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | 무상증자에 따른 주식매수선택권 수량변동 및 계약사항 변경 |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | 주식회사 엘앤씨바이오 | Company code | 290650 |
| Entity type | KOSDAQ-Listed Company | Total Issued Voting Shares (shares) | 61,107,168 |
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | 변동ㆍ변경 | Joint signatories |
| Reporting person type | Individual (Domestic) | Nationality | Republic of Korea |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | 이환철 | Chinese characters (English) | 李煥鐵(Lee whan-chul) |
| Address (Head Office) [Town/District Level Only] | 서울특별시 서초구 고무래로 | Date of Birth or Business Registration No., etc. | 760315 |
| Occupation (business) | Executive | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | 주식회사 엘앤씨바이오 | Department | 경영관리팀 |
| Position | Manager | Phone Number | 070-77*** |
| Name | 이종찬 | Fax number | 02-541* |
| Email address | **@lncbio.co.kr |
(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)
| Legal form | - |
| Total Assets (or Total Assets Under Management) | - | Total Liabilities | - |
| Total Equity | - | Paid-in Capital | - |
| Representative (representative or managing partner) | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Largest Investor) | - | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | - |
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | 황일선 | Individual (Domestic) | Relatives | 790301 | Republic of Korea | 서울시 성동구 고산자로 | - | Shareholder |
| 2 | 이미선 | Individual (Domestic) | Relatives | 570724 | Republic of Korea | 경기도 수원시 영통구 영통로 | - | Shareholder |
| 3 | 조건희 | Individual (Domestic) | Relatives | 740309 | Republic of Korea | 경기도 양주시 삼숭로 | - | Shareholder |
| 4 | 이지한 | Individual (Domestic) | Relatives | 071020 | Republic of Korea | 서울시 서초구 고무래로 | - | Shareholder |
| 5 | 이지성 | Individual (Domestic) | Relatives | 110201 | Republic of Korea | 서울시 서초구 고무래로 | - | Shareholder |
| 6 | 이재호 | Individual (Domestic) | Executive | 750504 | Republic of Korea | 서울시 강남구 광평로 | 주식회사 엘앤씨바이오 등기임원 | Executive officers (registered) |
| 7 | 신성훈 | Individual (Domestic) | Officer of Affiliate | 780220 | Republic of Korea | 부산시 해운대구 재송동 | 계열회사 등기임원 | Officers of affiliates, etc. |
| 8 | 김창수 | Individual (Domestic) | Officer of Affiliate | 730211 | Republic of Korea | 경기도 용인시 기흥구 마북로 | 계열회사 등기임원 | Officers of affiliates, etc. |
| 9 | 손석우 | Individual (Domestic) | Officer of Affiliate | 771008 | Republic of Korea | 경기도 구리시 갈매동 | 계열회사 등기임원 | Officers of affiliates, etc. |
| 10 | (주)글로벌의학연구센터 | Domestic corporation | Affiliate | 765-88-00920 | Republic of Korea | 서울특별시 서초구 나루터로 | 화장품 CRO, 의학 및 약학 연구개발 | Affiliates, etc. |
| 11 | 엘앤씨바이오 사내근로복지기금 | 기타단체(국내) | Other | 218-82-02022 | Republic of Korea | 경기도 성남시 중원구 둔촌대로 | 사내근로복지기금 | Other |
| * Address to town/district level only |
(2) 특별관계자에 대한 구체적인 사항(법인, 기타단체, 법령상조합, 민법상 조합의 경우 기재)① (주)글로벌의학연구센터
| (Record Date: | 2025-12-31 | ) | (Unit: KRW thousand) |
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 36,151,768 | Total Liabilities | 13,710,545 |
| Total Equity | 22,441,224 | Paid-in Capital | 1,666,023 |
| Representative (representative or managing partner) | 임두현 |
| Decision-Making Body (Decision Maker) | 이사회 및 주주총회 |
| Largest Shareholder (Largest Investor) | 주식회사엘앤씨바이오 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 48.30 |
② 엘앤씨바이오사내근로복지기금
| (Record Date: | 2025-12-31 | ) | (Unit: KRW thousand) |
| Legal form | 사내근로복지기금 |
| Total Assets (or Total Assets Under Management) | 6,807,042 | Total Liabilities | 5,586,150 |
| Total Equity | 1,220,892 | Paid-in Capital | 1,220,892 |
| Representative (representative or managing partner) | 이환철 |
| Decision-Making Body (Decision Maker) | 복지기금협의회 |
| Largest Shareholder (Largest Investor) | - | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | - |
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | 2026-10-30 | 이환철 | 11 | 12,584,444 | 20.59 | 12,459,444 | 20.39 | 61,107,168 |
| This Report | 2026-11-17 | 이환철 | 11 | 12,708,504 | 20.80 | 12,459,444 | 20.39 | 61,107,168 |
| Change | 124,060 | 0.21 | - | 0.00 | 0 |
4. Purpose of holding
| Impact on management control |
| 본인은 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호의 사항에 대하여 회사의 최대주주로서 영향력을 행사하고자 합니다. 회사의 업무집행과 관련한 각 호의사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다.- 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호(아래1~9호)1. 이사 및 감사의 선임.해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 회사의 합병,분할과 분할합병5. 주식의 포괄적 교환과 이전6. 영업전부의 양수.양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수,양도7. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분8. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이하는 계약,그 밖에 이에 준하는 계약의 체결,변경 또는 해약9. 회사의 해산 |
5. Reason for change
| Method of change | 무상증자에 따른 주식매수선택권 조정 |
| Reason for change | 무상증자에 따른 보유주식등의 내역 변동 |
| Reason for Change | 무상증자에 따른 주식담보대출 담보수량 변경 |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | 이환철 | 760315 | 11,856,044 | - | - | - | - | - | - | - | - | 11,856,044 | 19.40 |
| Specially Related Party | 황일선 | 790301 | 52,000 | - | - | - | - | - | - | - | - | 52,000 | 0.09 |
| 이미선 | 570724 | 72,000 | - | - | - | - | - | - | - | - | 72,000 | 0.12 |
| 조건희 | 740309 | 62,000 | - | - | - | - | - | - | - | - | 62,000 | 0.10 |
| 이지한 | 071020 | 16,640 | - | - | - | - | - | - | - | - | 16,640 | 0.03 |
| 이지성 | 110201 | 16,640 | - | - | - | - | - | - | - | - | 16,640 | 0.03 |
| 이재호 | 750504 | - | - | - | - | - | - | - | - | 199,250 | 199,250 | 0.33 |
| 신성훈 | 780220 | 35,892 | - | - | - | - | - | - | - | 9,962 | 45,854 | 0.08 |
| 김창수 | 730211 | - | - | - | - | - | - | - | - | 39,848 | 39,848 | 0.07 |
| 손석우 | 771008 | 8,436 | - | - | - | - | - | - | - | - | 8,436 | 0.01 |
| (주)글로벌의학연구센터 | 765-88-00920 | 39,536 | - | - | - | - | - | - | - | - | 39,536 | 0.06 |
| 엘앤씨바이오사내근로복지기금 | 218-82-02022 | 300,256 | - | - | - | - | - | - | - | - | 300,256 | 0.49 |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 61,107,168 | 249,060 | 20.80 | 20.39 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | 이환철 | 760315 | 11,856,044 | - | - | - | - | - | - | 11,856,044 | 19.40 |
| Specially Related Party | 황일선 | 790301 | 52,000 | - | - | - | - | - | - | 52,000 | 0.09 |
| 이미선 | 570724 | 72,000 | - | - | - | - | - | - | 72,000 | 0.12 |
| 조건희 | 740309 | 62,000 | - | - | - | - | - | - | 62,000 | 0.10 |
| 이지한 | 071020 | 16,640 | - | - | - | - | - | - | 16,640 | 0.03 |
| 이지성 | 110201 | 16,640 | - | - | - | - | - | - | 16,640 | 0.03 |
| 이재호 | 750504 | - | - | - | - | - | - | 199,250 | 199,250 | 0.33 |
| 신성훈 | 780220 | 35,892 | - | - | - | - | - | 9,962 | 45,854 | 0.08 |
| 김창수 | 730211 | - | - | - | - | - | - | 39,848 | 39,848 | 0.07 |
| 손석우 | 771008 | 8,436 | - | - | - | - | - | - | 8,436 | 0.01 |
| (주)글로벌의학연구센터 | 765-88-00920 | 39,536 | - | - | - | - | - | - | 39,536 | 0.06 |
| 엘앤씨바이오 사내근로복지기금 | 218-82-02022 | 300,256 | - | - | - | - | - | - | 300,256 | 0.49 |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| Yes |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| 1 | 이환철 | Self | 760315 | Voting Shares | 3,800,000 | 한국증권금융 | 담보계약 | 2026-11-12 | 2019.10.28 ~ 2027.04.28(1회차)2023.04.14 ~ 2027.04.14(3회차) | 6.22 | Stock-Backed Loan |
| Total (number of shares, etc.) | 3,800,000 | Total (ratio) | 6.22 | - |
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| 1 | 3,800,000 | 17,000,000,000 | 이환철 | 5.44 | 110 | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | 이환철 | 760315 | - | - | - | - | - | - | - | - | - | - | - |
| Specially Related Party | 황일선 | 790301 | - | - | - | - | - | - | - | - | - | - | - |
| 이미선 | 570724 | - | - | - | - | - | - | - | - | - | - | - |
| 조건희 | 740309 | - | - | - | - | - | - | - | - | - | - | - |
| 이지한 | 071020 | - | - | - | - | - | - | - | - | - | - | - |
| 이지성 | 110201 | - | - | - | - | - | - | - | - | - | - | - |
| 이재호 | 750504 | - | - | - | - | - | - | - | - | 99,250 | 99,250 | 0.17 |
| 신성훈 | 780220 | - | - | - | - | - | - | - | - | 4,962 | 4,962 | 0.01 |
| 김창수 | 730211 | - | - | - | - | - | - | - | - | 19,848 | 19,848 | 0.04 |
| 손석우 | 771008 | - | - | - | - | - | - | - | - | - | - | - |
| (주)글로벌의학연구센터 | 765-88-00920 | - | - | - | - | - | - | - | - | - | - | - |
| 엘앤씨바이오 사내근로복지기금 | 218-82-02022 | - | - | - | - | - | - | - | - | - | - | - |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| 이재호 | 750504 | 2026-11-09 | 기타(+) | Other | 100,000 | 99,250 | 199,250 | - | - | 무상증자에 의한 주식매수선택권 조정 |
| 신성훈 | 780220 | 2026-11-09 | 기타(+) | Other | 5,000 | 4,962 | 9,962 | - | - | 무상증자에 의한 주식매수선택권 조정 |
| 김창수 | 730211 | 2026-11-09 | 기타(+) | Other | 20,000 | 19,848 | 39,848 | - | - | 무상증자에 의한 주식매수선택권 조정 |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| 이재호 | 750504 | - | - | 99,250 | 99,250 |
| 신성훈 | 780220 | - | - | 4,962 | 4,962 |
| 김창수 | 730211 | - | - | 19,848 | 19,848 |
주) '기타(J)'는 무상증자에 따른 주식매수선택권 조정수량을 기재하였습니다.
(2) Origin and source of acquisition funds
ㅇ 기타의 경우
| Name | Date of birth or business registration no., etc. | Source and Formation of Acquisition Funds |
| 이재호 | 750504 | 무상증자에 의한 주식매수선택권 조정 |
| 신성훈 | 780220 | 무상증자에 의한 주식매수선택권 조정 |
| 김창수 | 730211 | 무상증자에 의한 주식매수선택권 조정 |